Iceland - Hospital Average Length of Stay for Carcinoma in Situ
Since 2014, Iceland Hospital Average Length of Stay for Carcinoma in Situ grew 10.6% year on year. At 4.3 Days in 2019, the country was number 6 among other countries in Hospital Average Length of Stay for Carcinoma in Situ. Iceland is overtaken by Israel, which was number 5 with 4.8 Days and is followed by Poland with 4.1 Days. South Korea topped the ranking with 7.5 Days in 2019, that is -2.6% versus 2018. Slovakia, Latvia and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +10.6% per year, while New Zealand recorded the worst performance at -8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 4.30 |
| 2018 | 4.30 |
| 2017 | 4.80 |
| 2016 | 3.30 |
| 2015 |
Download all data from 2000 to 2019
How does Iceland rank in Hospital Average Length of Stay for Carcinoma in Situ?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
7.50 | 2019 | -2.6 % | +0.8 % | View data | |
| 2 |
#2
Slovakia
|
5.40 | 2019 | +0.0 % | +0.4 % | View data | |
| 5 |
#5
Israel
|
4.80 | 2019 | +6.7 % | +0.8 % | View data | |
| 6 |
#6
Iceland
|
4.30 | 2019 | +0.0 % | +10.6 % | View data | |
| 7 |
#7
Italy
|
4.10 | 2019 | -2.4 % | -0.9 % | View data | |